Men | Women | |||||
---|---|---|---|---|---|---|
Case/Total | Crude prevalence % (95% CI) | Age-standardized prevalence a % (95% CI) | Case/Total | Crude prevalence % (95% CI) | Age-standardized prevalence a % (95% CI) | |
NFG/NGT | 139/1891 | 7.35 (6.17–8.53) | 7.28 (6.06–8.49) | 108/2531 | 4.27 (3.48–5.05) | 5.71 (4.62–6.79) |
Prediabetes (IFG or IGT) | 126/1000 | 12.60 (10.54–14.66) | 7.95 (6.55–9.36) | 88/1040 | 8.46 (6.77–10.15) | 6.62 (5.06–8.19) |
DM | 133/536 | 24.81 (21.15–28.47) | 13.10 (9.83–16.38) | 156/720 | 21.67 (18.65–24.68) | 10.67 (8.90–12.44) |
Total | 398/3427 | 11.61 (10.54–12.69) | 8.62 (7.81–9.44) | 352/4291 | 8.20 (7.38–9.02) | 7.19 (6.46–7.93) |